Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2016 1
2017 2
2018 1
2020 1
2021 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Dysprosium site occupancy in SrZnO2 nanophosphors probed through XANES.
Manju, Rajput P, Vij A, Thakur A. Manju, et al. Phys Chem Chem Phys. 2023 Oct 25;25(41):28473-28478. doi: 10.1039/d3cp03041e. Phys Chem Chem Phys. 2023. PMID: 37846758
The real space full multiple scattering-based simulations of the Zn K-edge are done by substituting Dy at cationic sites in the second coordination shell around Zn, in various combinations along with and/or without oxygen vacancies in the system. The results revealed that …
The real space full multiple scattering-based simulations of the Zn K-edge are done by substituting Dy at cationic sites in the secon …
Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.
Sasidharan R, Eom BH, Heo JH, Park JE, Abdelgawad MA, Musa A, Gambacorta N, Nicolotti O, Manju SL, Mathew B, Kim H. Sasidharan R, et al. J Enzyme Inhib Med Chem. 2021 Dec;36(1):188-197. doi: 10.1080/14756366.2020.1842390. J Enzyme Inhib Med Chem. 2021. PMID: 33430657 Free PMC article.
Most of the compounds potently inhibited MAO-B; MO1 most potently inhibited with an IC(50) value of 0.030 M, followed by MO7 (0.25 M). MO5 most potently inhibited AChE (IC(50) = 6.1 M), followed by MO9 (IC(50) = 12.01 M) and MO7 most potently inhibited …
Most of the compounds potently inhibited MAO-B; MO1 most potently inhibited with an IC(50) value of 0.030 M, followed by MO7 (0.25 …
Clinical Phenotype in Individuals With Birk-Landau-Perez Syndrome Associated With Biallelic SLC30A9 Pathogenic Variants.
Steel DBD, Danti FR, Abunada M, Kamien B, Malhotra S, Topf M, Kaliakatsos M, Valentine J, Nemeth AH, Jayawant S, Reid KM, Mankad K, Sudhakar S, Ben-Pazi H, Barwick K, Kurian MA. Steel DBD, et al. Neurology. 2023 May 23;100(21):e2214-e2223. doi: 10.1212/WNL.0000000000207241. Epub 2023 Apr 11. Neurology. 2023. PMID: 37041080 Free PMC article.
Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy.
McTague A, Nair U, Malhotra S, Meyer E, Trump N, Gazina EV, Papandreou A, Ngoh A, Ackermann S, Ambegaonkar G, Appleton R, Desurkar A, Eltze C, Kneen R, Kumar AV, Lascelles K, Montgomery T, Ramesh V, Samanta R, Scott RH, Tan J, Whitehouse W, Poduri A, Scheffer IE, Chong WKK, Cross JH, Topf M, Petrou S, Kurian MA. McTague A, et al. Neurology. 2018 Jan 2;90(1):e55-e66. doi: 10.1212/WNL.0000000000004762. Epub 2017 Dec 1. Neurology. 2018. PMID: 29196579 Free PMC article.
RHOBTB2 Mutations Expand the Phenotypic Spectrum of Alternating Hemiplegia of Childhood.
Zagaglia S, Steel D, Krithika S, Hernandez-Hernandez L, Custodio HM, Gorman KM, Vezyroglou A, Møller RS, King MD, Hammer TB, Spaull R, Fazeli W, Bartolomaeus T, Doummar D, Keren B, Mignot C, Bednarek N, Cross JH, Mallick AA, Sanchis-Juan A, Basu A, Raymond FL, Lynch BJ, Majumdar A, Stamberger H, Weckhuysen S, Sisodiya SM, Kurian MA. Zagaglia S, et al. Neurology. 2021 Mar 16;96(11):e1539-e1550. doi: 10.1212/WNL.0000000000011543. Epub 2021 Jan 27. Neurology. 2021. PMID: 33504645 Free PMC article.
Delineation of the movement disorders associated with FOXG1 mutations.
Papandreou A, Schneider RB, Augustine EF, Ng J, Mankad K, Meyer E, McTague A, Ngoh A, Hemingway C, Robinson R, Varadkar SM, Kinali M, Salpietro V, O'Driscoll MC, Basheer SN, Webster RI, Mohammad SS, Pula S, McGowan M, Trump N, Jenkins L, Elmslie F, Scott RH, Hurst JA, Perez-Duenas B, Paciorkowski AR, Kurian MA. Papandreou A, et al. Neurology. 2016 May 10;86(19):1794-800. doi: 10.1212/WNL.0000000000002585. Epub 2016 Mar 30. Neurology. 2016. PMID: 27029630 Free PMC article.
Observation of short range ferromagnetic interactions and magnetocaloric effect in cobalt substituted Gd5Si2Ge2.
Uthaman B, Manju P, Thomas S, Jaiswal Nagar D, Suresh KG, Varma MR. Uthaman B, et al. Phys Chem Chem Phys. 2017 May 17;19(19):12282-12295. doi: 10.1039/c7cp00849j. Phys Chem Chem Phys. 2017. PMID: 28451661
The magnetostructural transition results in entropy changes (-deltaS(M)) of 9 J kg(-1) K(-1) at 260 K for x = 0.1, 8.5 J kg(-1) K(-1) at 245 K for x = 0.2 and 4.2 J kg(-1) K(-1) at 210 K for x = 0.4 for a field change of 50 kOe. .. …
The magnetostructural transition results in entropy changes (-deltaS(M)) of 9 J kg(-1) K(-1) at 260 K for x = 0.1, 8.5 …
Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.
Chandran M, Mitchell PJ, Amphansap T, Bhadada SK, Chadha M, Chan DC, Chung YS, Ebeling P, Gilchrist N, Habib Khan A, Halbout P, Hew FL, Lan HT, Lau TC, Lee JK, Lekamwasam S, Lyubomirsky G, Mercado-Asis LB, Mithal A, Nguyen TV, Pandey D, Reid IR, Suzuki A, Chit TT, Tiu KL, Valleenukul T, Yung CK, Zhao YL; Asia Pacific Consortium on Osteoporosis (APCO). Chandran M, et al. Osteoporos Int. 2021 Jul;32(7):1249-1275. doi: 10.1007/s00198-020-05742-0. Epub 2021 Jan 27. Osteoporos Int. 2021. PMID: 33502559 Free PMC article.
Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.
ICMR COVID Study Group (In alphabetical order: Priya Abraham†, Neeraj Aggarwa l2, Giridhara R. Babu 7, Suganya Barani 8, Balram Bhargava 4, Tarun Bhatnagar 8, Ajay Singh Dhama 3, Raman R. Gangakhedkar 2, Sidhartha Giri 2, Nivedita Gupta 2, Karishma K. Kurup 5, Ponnaiah Manickam 9, Manoj Murhekar ††, Varsha Potdar 1, Ira Praharaj 2, Kiran Rade 6, D.C.S. Reddy 11, V. Saravanakumar 10, Naman Shah 12, Harpreet Singh 3, Jeromie Wesley Vivian Thangaraj 8, Naveen Yadav 8), COVID Epidemiology & Data Management Team @, COVID Laboratory Team*, VRDLN Team$; @COVID Epidemiology & Data Management Team (in alphabetical order): Tanu Anand, Harish Kumar Butollia, Pranab Chatterjee, Himanshu Chauhan, R Deepa, Amirthammal Gunasekaran, Daisy A John, Shashi Kant, Sanket Kulkarni, Vinit Kumar, JP Muliyil, Ravindra Mohan Pandey, Swarup Sarkar, Sujeet Singh, Sanjay Zodpey; *COVID Laboratory Team (in alphabetical order): Srima Adhikari, Jyotsna Agarwal, Naveen KumarAgarwal, Saurabh G Agarwal, Prerna Aggarwal, Anurag Agrawal, Arti Agrawal, Safaa Muneer Ahmed, G Ambernath, Nitin Ambhore, VP Amudha, Sohini Arora, Ashok, Anita, Awanti, Veer Badriyah TA, Amrita Kumari B, Maneesh Bagai, Dipa Baido, Bai… See abstract for full author list ➔ ICMR COVID Study Group (In alphabetical order: Priya Abraham†, Neeraj Aggarwa l2, Giridhara R. Babu 7, Suganya Barani 8, Balram Bhargava 4, Tarun Bhatnagar 8, Ajay Singh Dhama 3, Raman R. Gangakhedkar 2, Sidhartha Giri 2, Nivedita Gupta 2, Karishma K. Kurup 5, Ponnaiah Manickam 9, Manoj Murhekar ††, Varsha Potdar 1, Ira Praharaj 2, Kiran Rade 6, D.C.S. Reddy 11, V. Saravanakumar 10, Naman Shah 12, Harpreet Singh 3, Jeromie Wesley Vivian Thangaraj 8, Naveen Yadav 8), COVID Epidemiology & Data Management Team @, COVID Laboratory Team*, VRDLN Team$, et al. Indian J Med Res. 2020 May;151(5):424-437. doi: 10.4103/ijmr.IJMR_1896_20. Indian J Med Res. 2020. PMID: 32611914 Free PMC article.
Purification and characterization of two thermostable xylanases from Malbranchea flava active under alkaline conditions.
Sharma M, Chadha BS, Saini HS. Sharma M, et al. Bioresour Technol. 2010 Nov;101(22):8834-42. doi: 10.1016/j.biortech.2010.06.071. Epub 2010 Jul 13. Bioresour Technol. 2010. PMID: 20630749
The xylanases were optimally active at pH 9.0 and at 60 degrees C, exhibited a half-life of 4h at 60 degrees C, and showed distinct mode of action and product profiles when applied to birchwood, oat spelt, and larchwood xylan, and to wheat and rye arabinoxylan. The xylanases were …
The xylanases were optimally active at pH 9.0 and at 60 degrees C, exhibited a half-life of 4h at 60 degrees C, and showed distinct mode of …